|
|
| Considering outsourcing development and manufacturing? The Outsourced Pharma Capacity Update (OPCU), a free, interactive, digital event, convenes the industry's foremost CDMOs to provide up-to-date and direct insights into their available capacity and services, alongside specific facility and equipment updates. Discover the July 2025 event’s presenting sponsors in this newsletter to learn how they are best suited to help you to navigate the path to approval and commercialization. |
|
|
LARGE MOLECULE DRUG SUBSTANCE & DEVELOPMENT |
|
|
Aragen | Aragen’s newly built cutting-edge biologics manufacturing facility launches with GMP capabilities from 50L to 2000L with a DP filling line and ADC conjugation suite set to redefine bioproduction in India. | Request Information | Aragen |
|
|
FUJIFILM Biotechnologies | Explore the strategic application of extensive expertise in microbial systems to meet increasing demand. Cutting-edge capabilities ensure streamlined development and manufacturing processes. | Request Information | FUJIFILM Biotechnologies |
|
|
Cytovance Biologics | Thomas Kohl, Director of Business Development, shares microbial and mammalian capabilities and available capacity. Cytovance delivers ingenuity end-to-end to both large pharma and biotech clients. | Request Information | Cytovance Biologics |
|
|
Novartis Contract Manufacturing | Review biologics CDMO solutions and capacity offered by Novartis Contract Manufacturing. Review capabilities in mammalian cell culture manufacturing and microbial fermentation. | Request Information | Novartis Contract Manufacturing |
|
|
Resilience US, Inc. | Hear from Evan Pasenello, Head of Commercial Services, about how Resilience can support large molecule programs from early phase through clinical and commercial manufacturing. | Request Information | Resilience US, Inc. |
|
|
|
Lonza | Leveraging Lonza's deep ADC expertise and experience, successfully develop high quality, commercially viable processes, spanning from pre-clinical development through commercial scale manufacturing. | Request Information | Lonza |
|
|
MilliporeSigma | With more than 15 years of experience as conjugation and linker-payload CDMO, MilliporeSigma has a proven track record of supporting clinical programs from IND to PPQ for commercialization. | Request Information | MilliporeSigma |
|
|
Simtra BioPharma Solutions | With more than 65 years of sterile injectable manufacturing experience, Simtra offers world-class GMP sterile fill/finish services, deep scientific and technical expertise, and a uniquely collaborative approach. | Request Information | Simtra BioPharma Solutions |
|
|
|
|
